Corrigendum: Diagnosis and management of neurofibromatosis type 1 in Arabian Gulf Cooperation Council Region: challenges and recommendations

Affiliations

• ¹ Division of Pediatric Neurology, Department of Pediatrics, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
• ² Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
• ³ Neuroscience Centre, King Faisal Specialist Hospital and Research Centre, College of Medicine, Al Faisal University, Riyadh, Saudi Arabia.
• ⁴ Consultant of Neuro-oncology and Neuromuscular-neurology, Department of Oncology, King Faisal Specialist Hospital and Research Centre, Department of Neuroscience, King Faisal Specialist Hospital and Research Centre, Al Faisal University, Riyadh, Saudi Arabia.
• ⁵ Sultan Qaboos University, College of Medicine and Health Sciences, Muscat, Oman.
• ⁶ Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
• ⁷ Pediatric Neurology Unit, Pediatric Department, AlSabah Hospital, Ministry of Health, Kuwait City, Kuwait.
• ⁸ Department of Oncology, King Faisal Specialist Hospital & Research Center - Jeddah (KFSHRC-Jed), Jeddah, Saudi Arabia.
• ⁹ HemOnc Division, Department of Child Health, Sidra Medicine, Doha, Qatar.
• ¹⁰ Pediatric Hematology-Oncology Department, Al Jalila children's specialty Hospital, Dubai, United Arab Emirates.
• ¹¹ Division of Medical Genetics, Department of Pediatrics, King Khalid University Hospital, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
• ¹² Neuroscience Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
• ¹³ Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.